Stay updated on Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for the completed Phase 3 tapinarof study is now displayed, including its design, participant criteria, results, and related publications. The record also provides study documents and historical registration and update dates.SummaryDifference81%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden message rather than the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page. The site revision changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.SummaryDifference1%

- Check37 days agoChange DetectedThe page remains a 403 Forbidden error screen; the footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record details with an access-denied message. This change affects whether the study information is viewable rather than presenting new substantive content.SummaryDifference18%

- Check58 days agoChange DetectedThe page's revision banner changes from v3.6.6 to v3.7.0. This reflects a front-end version update rather than any modification to the study content.SummaryDifference0.0%

Stay in the know with updates to Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.